UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Motco

Motco decreased its position in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 2.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,943 shares of the healthcare conglomerate’s stock after selling 499 shares during the period. Motco’s holdings in UnitedHealth Group were worth $10,014,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently modified their holdings of the company. Outfitter Financial LLC purchased a new position in UnitedHealth Group in the 4th quarter worth $25,000. Blue Bell Private Wealth Management LLC purchased a new position in UnitedHealth Group in the 4th quarter worth $29,000. Stuart Chaussee & Associates Inc. raised its stake in UnitedHealth Group by 55.6% in the 4th quarter. Stuart Chaussee & Associates Inc. now owns 70 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 25 shares during the last quarter. Annapolis Financial Services LLC raised its stake in UnitedHealth Group by 57.9% in the 3rd quarter. Annapolis Financial Services LLC now owns 90 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 33 shares during the last quarter. Finally, Level Financial Advisors Inc. purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at about $45,000. Institutional investors own 86.07% of the company’s stock.

In other UnitedHealth Group news, Director Richard T. Burke sold 3,000 shares of the company’s stock in a transaction on Thursday, March 24th. The shares were sold at an average price of $508.80, for a total value of $1,526,400.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Richard T. Burke sold 5,000 shares of the company’s stock in a transaction on Wednesday, February 16th. The shares were sold at an average price of $476.72, for a total transaction of $2,383,600.00. The disclosure for this sale can be found here. In the last three months, insiders sold 18,000 shares of company stock worth $8,776,840. 0.55% of the stock is owned by corporate insiders.

UNH has been the subject of a number of recent research reports. Truist Financial lifted their price objective on UnitedHealth Group from $575.00 to $610.00 in a research note on Thursday, April 7th. Edward Jones began coverage on UnitedHealth Group in a research note on Monday, January 10th. They issued a “buy” rating for the company. Cowen lifted their price objective on UnitedHealth Group from $512.00 to $596.00 in a report on Monday, April 18th. Sanford C. Bernstein lifted their price objective on UnitedHealth Group from $508.00 to $564.00 in a report on Tuesday, January 11th. Finally, Wells Fargo & Company lifted their price objective on UnitedHealth Group from $565.00 to $613.00 and gave the stock an “overweight” rating in a report on Friday, April 22nd. Two analysts have rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $550.17.

UNH traded down $15.87 during trading hours on Friday, reaching $508.55. The company’s stock had a trading volume of 2,873,166 shares, compared to its average volume of 2,999,332. UnitedHealth Group Incorporated has a fifty-two week low of $383.12 and a fifty-two week high of $553.29. The stock has a market cap of $477.50 billion, a PE ratio of 27.84, a P/E/G ratio of 1.60 and a beta of 0.88. The business’s 50-day moving average is $507.83 and its 200-day moving average is $480.33. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.78 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNHGet Rating) last released its quarterly earnings data on Thursday, April 14th. The healthcare conglomerate reported $5.49 EPS for the quarter, beating analysts’ consensus estimates of $5.38 by $0.11. UnitedHealth Group had a return on equity of 24.74% and a net margin of 5.86%. The firm had revenue of $80.15 billion for the quarter, compared to analysts’ expectations of $78.77 billion. During the same period in the prior year, the firm posted $5.31 earnings per share. The firm’s quarterly revenue was up 14.2% on a year-over-year basis. Analysts expect that UnitedHealth Group Incorporated will post 21.75 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 22nd. Shareholders of record on Monday, March 14th were given a $1.45 dividend. This represents a $5.80 dividend on an annualized basis and a yield of 1.14%. The ex-dividend date was Friday, March 11th. UnitedHealth Group’s payout ratio is 31.75%.

UnitedHealth Group Company Profile (Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.